Taïeb D - Search Results

1

Heath-related quality of life in thyroid cancer patients following radioiodine ablation.

Taïeb D, Baumstarck-Barrau K, Sebag F, Fortanier C, De Micco C, Loundou A, Auquier P, Palazzo FF, Henry JF, Mundler O. Taïeb D, et al. Health Qual Life Outcomes. 2011 May 13;9:33. doi: 10.1186/1477-7525-9-33. Health Qual Life Outcomes. 2011. PMID: 21569494 Free PMC article.

2

Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?

Taïeb D, Sebag F, Hubbard JG, Mundler O, Henry JF, Conte-Devolx B. Taïeb D, et al. Clin Endocrinol (Oxf). 2004 Jul;61(1):102-8. doi: 10.1111/j.1365-2265.2004.02077.x. Clin Endocrinol (Oxf). 2004. PMID: 15212651

3

Subcutaneous administration of recombinant human thyrotropin as an alternative to thyroid hormone withdrawal in patients with anticoagulated thyroid cancer: preliminary results.

Taïeb D, Lussato D, Mundler O. Taïeb D, et al. Thyroid. 2004 Jun;14(6):463-4. doi: 10.1089/105072504323150796. Thyroid. 2004. PMID: 15242575 Clinical Trial.

4

Lack of efficacy of recombinant human thyrotropin versus thyroid hormone withdrawal for radioiodine therapy imaging in a patient with differentiated thyroid carcinoma lung metastases.

Taïeb D, Jacob T, Zotian E, Mundler O. Taïeb D, et al. Thyroid. 2004 Jun;14(6):465-7. doi: 10.1089/105072504323150804. Thyroid. 2004. PMID: 15242576

5

Incidental diagnosis of struma ovarii after thyroidectomy for thyroid cancer: functional imaging studies and follow-up.

Ghander C, Lussato D, Conte Devolx B, Mundler O, Taïeb D. Ghander C, et al. Among authors: taieb d. Gynecol Oncol. 2006 Aug;102(2):378-80. doi: 10.1016/j.ygyno.2006.01.047. Epub 2006 Mar 6. Gynecol Oncol. 2006. PMID: 16516952

6

Early sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.

Taïeb D, Lussato D, Guedj E, Roux F, Mundler O. Taïeb D, et al. Thyroid. 2006 Feb;16(2):177-9. doi: 10.1089/thy.2006.16.177. Thyroid. 2006. PMID: 16676403

7

99mTc-ECD brain perfusion SPECT in hyperalgesic fibromyalgia.

Guedj E, Taieb D, Cammilleri S, Lussato D, de Laforte C, Niboyet J, Mundler O. Guedj E, et al. Among authors: taieb d. Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):130-4. doi: 10.1007/s00259-006-0174-7. Epub 2006 Aug 25. Eur J Nucl Med Mol Imaging. 2007. PMID: 16933135

8

Predictive value of brain perfusion SPECT for ketamine response in hyperalgesic fibromyalgia.

Guedj E, Cammilleri S, Colavolpe C, Taieb D, de Laforte C, Niboyet J, Mundler O. Guedj E, et al. Among authors: taieb d. Eur J Nucl Med Mol Imaging. 2007 Aug;34(8):1274-9. doi: 10.1007/s00259-007-0392-7. Epub 2007 Mar 13. Eur J Nucl Med Mol Imaging. 2007. PMID: 17431615

9

Tomoscintigraphy improves the determination of the embryologic origin of parathyroid adenomas, especially in apparently inferior glands: imaging features and surgical implications.

Taïeb D, Hassad R, Sebag F, Colavolpe C, Guedj E, Hindié E, Henry JF, Mundler O. Taïeb D, et al. J Nucl Med Technol. 2007 Sep;35(3):135-9. doi: 10.2967/jnmt.107.039743. Epub 2007 Aug 16. J Nucl Med Technol. 2007. PMID: 17702904 Free article.

10

The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.

Taïeb D, Tessonnier L, Sebag F, Niccoli-Sire P, Morange I, Colavolpe C, De Micco C, Barlier A, Palazzo FF, Henry JF, Mundler O. Taïeb D, et al. Clin Endocrinol (Oxf). 2008 Oct;69(4):580-6. doi: 10.1111/j.1365-2265.2008.03257.x. Epub 2008 Apr 3. Clin Endocrinol (Oxf). 2008. PMID: 18394015

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters